Public Buy-In Of Personalized Medicine Requires Dialogue – Tufts’ Kaitin
Improving the general public's understanding of drug development and delivery will be necessary to fully leverage the potential of personalized medicine, Tufts Center for the Study of Drug Development Director Kenneth Kaitin said
You may also be interested in...
PhRMA's Partnership for Prescription Assistance could serve as a template for future outreach efforts by the pharmaceutical industry, incoming Chairman Peter Dolan (Bristol-Myers Squibb) suggested
The Pharmaceutical Research & Manufacturers of America's principles for the use of evidence-based medicine emphasize that such data be used to "empower" patients and physicians
PhRMA is giving itself one year to monitor member companies' implementation of its new direct-to-consumer "guiding principles" before an independent panel will begin analyzing compliance and progress